2024/10/18 08:08:07 | |
---|---|
Price | |
28.94 EUR | |
Difference | 0.49% (0.14) |
ISIN | FR0000120859 |
Symbol | NK |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 2,494 EUR |
Benchmark | CAC 40 INDEX |
Bid (Bid size) | 29.44 EUR (40) |
Ask (Ask size) | 29.52 EUR (40) |
Open | 28.94 EUR |
High | 28.94 EUR |
Low | 28.94 EUR |
Close (prev. day) | 28.80 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | 14 |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 08:08:07 | |
---|---|
Price | |
28.94 EUR | |
Difference | 0.49% (0.14) |
ISIN | FR0000120859 |
Symbol | NK |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 2,494 EUR |
Benchmark | CAC 40 INDEX |
Bid (Bid size) | 29.44 EUR (40) |
Ask (Ask size) | 29.52 EUR (40) |
Open | 28.94 EUR |
High | 28.94 EUR |
Low | 28.94 EUR |
Close (prev. day) | 28.80 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -0.21% | +15.58% | -22.37% |
Perf (abs.) | -0.06 | +3.90 | -8.34 |
Beta | 1.11 | 1.15 | 0.97 |
Volatility | 30.03 | 32.54 | 30.71 |
Ø price 5 days | Ø volume 5 days (pcs.) | 28.98 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 29.56 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 31.94 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 30.43 EUR (1) |
YTD High | date | 38.28 EUR (2024/06/05) |
YTD Low | date | 25.42 EUR (2024/01/18) |
52 Weeks High | date | 38.28 EUR (2024/06/05) |
52 Weeks Low | date | 23.40 EUR (2023/10/31) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/18 | 22:26 | 29.50 EUR | 0.00 | 4 |
Stuttgart | 2024/10/18 | 15:47 | 29.54 EUR | 0.00 | 10 |
Munich | 2024/10/18 | 10:15 | 29.28 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2024/10/18 | 17:30 | 29.33 EUR | 0.01 | 2 |
Frankfurt | 2024/10/18 | 08:03 | 28.96 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/10/07 | 17:19 | 32.80 USD | 0.00 | 2 |
Euronext Paris | 2024/10/18 | 17:36 | 29.36 EUR | 1.02 | 597 |
Euronext Milan MTF Trading After Hours | - | - | - | 0.00 | - |
Duesseldorf | 2024/10/18 | 08:10 | 28.74 EUR | 0.00 | 3 |
Berlin | 2024/10/18 | 08:08 | 28.94 EUR | 0.00 | 2 |
IMERYS SA |
- - |
rue de l'Université 154 75007 Paris |
Telefon: +33 (0)1 49 55 63 00 |
Fax: +33 (0)1 49 55 63 01 |
E-mail: actionnaires@imerys.com |
- |
Alessandro Dazza | Chairman of Managing Board |
Cyril Giraud | Member of Executive Committee |
Frédérique Berthier-Raymond | Member of Executive Committee |
Guillaume Delacroix | Member of Executive Committee |
Jean-François Claver | Member of Executive Committee |
Jim Murberger | Member of Executive Committee |
Michel Cornelissen | Member of Executive Committee |
Olivier Pirotte | Member of Executive Committee |
Philippe Bourg | Member of Executive Committee |
Sébastien Rouge | Member of Executive Committee |
Vincent Lecerf | Member of Executive Committee |
Patrick Kron | Chairman of Supervisory Board |
Annette Messemer | Member of Supervisory Board |
Bernard-Pierre Delpit | Member of Supervisory Board |
Carlos Manuel Pérez Fernández | Member of Supervisory Board |
Dominique Morin | Member of Supervisory Board |
Ian Gallienne | Member of Supervisory Board |
Laurent Raets | Member of Supervisory Board |
Lucile Ribot | Member of Supervisory Board |
Marie-Françoise Walbaum | Member of Supervisory Board |
Paris Kyriacopoulos | Member of Supervisory Board |
Rein Dirkx | Member of Supervisory Board |
Stéphanie Besnier | Member of Supervisory Board |
Véronique Saubot | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer